glp-1 trials It Is a Huge Market. The Pipeline Is Full. More GLP-1s Are On Their Way The GLP-1 revolution: What UAB

Discussion In this study, we have developed a novel AML-specific drug-delivery system, TLR2 pep conjugated oridonin-liposome

Since the human genome contains only one glutathione synthetase gene, the various clinical forms of glutathione synthetase deficiency reflect different mutations or epigenetic modifications in the glutathione synthetase gene

A new federal multidistrict litigation docket has been established to centralize lawsuits alleging that glucagonlike peptide1 (GLP1) receptor agonist drugs, including Ozempic, Wegovy, Rybelsus, Mounjaro, and others, caused serious vision loss linked to nonarteritic anterior ischemic optic neuropathy (NAION)

In the MISER trial reported by Bang et al., 26 of 32 surgical patients (81.3%) underwent cystogastrostomy, while three patients were converted to endoscopic management because of intraoperative cardiovascular instability or technical failure